• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昆虫细胞表达的p180erbB3具有受损的酪氨酸激酶活性。

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.

作者信息

Guy P M, Platko J V, Cantley L C, Cerione R A, Carraway K L

机构信息

Department of Pharmacology, Cornell University, Ithaca, NY 14853.

出版信息

Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8132-6. doi: 10.1073/pnas.91.17.8132.

DOI:10.1073/pnas.91.17.8132
PMID:8058768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC44559/
Abstract

Protein kinases share a number of highly conserved or invariant amino acid residues in their catalytic domains, suggesting that these residues are necessary for kinase activity. In p180erbB3, a receptor tyrosine kinase belonging to the epidermal growth factor (EGF) receptor subfamily, three of these residues are altered, suggesting that this protein might have an impaired protein tyrosine kinase activity. To test this hypothesis, we have expressed human EGF receptor and bovine p180erbB3 in insect cells via baculovirus infection and have compared their autophosphorylation and substrate phosphorylation activities. We have found that, while the EGF receptor readily undergoes EGF-stimulated autophosphorylation and catalyzes the incorporation of phosphate into the model substrates (E4Y1)n (random 4:1 copolymer of glutamic acid and tyrosine) and GST-p85 (glutathione S-transferase fusion protein with the 85-kDa subunit of phosphatidylinositol 3-kinase), p180erbB3 autophosphorylation and substrate phosphorylation are at least 2 orders of magnitude less efficient. However, p180erbB3 is capable of binding the ATP analog 5'-p-fluorosulfonylbenzoyladenosine, indicating that the lack of observed kinase activity is probably not due to nonfunctional or denatured receptors expressed by the insect cells. On the basis of these results, we propose that p180erbB3 possesses an impaired intrinsic tyrosine kinase activity.

摘要

蛋白激酶在其催化结构域中共有一些高度保守或不变的氨基酸残基,这表明这些残基对于激酶活性是必需的。在p180erbB3(一种属于表皮生长因子(EGF)受体亚家族的受体酪氨酸激酶)中,其中三个这样的残基发生了改变,这表明该蛋白可能具有受损的蛋白酪氨酸激酶活性。为了验证这一假设,我们通过杆状病毒感染在昆虫细胞中表达了人EGF受体和牛p180erbB3,并比较了它们的自磷酸化和底物磷酸化活性。我们发现,虽然EGF受体很容易发生EGF刺激的自磷酸化,并催化将磷酸掺入模型底物(E4Y1)n(谷氨酸和酪氨酸的随机4:1共聚物)和GST-p85(与磷脂酰肌醇3激酶的85-kDa亚基的谷胱甘肽S-转移酶融合蛋白)中,但p180erbB3的自磷酸化和底物磷酸化效率至少低2个数量级。然而,p180erbB3能够结合ATP类似物5'-p-氟磺酰苯甲酰腺苷,这表明观察到的激酶活性缺乏可能不是由于昆虫细胞表达的无功能或变性受体所致。基于这些结果,我们提出p180erbB3具有受损的内在酪氨酸激酶活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3714/44559/c664c2019e02/pnas01139-0312-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3714/44559/e0bb7af39208/pnas01139-0310-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3714/44559/8a5e1d564725/pnas01139-0311-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3714/44559/c664c2019e02/pnas01139-0312-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3714/44559/e0bb7af39208/pnas01139-0310-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3714/44559/8a5e1d564725/pnas01139-0311-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3714/44559/c664c2019e02/pnas01139-0312-a.jpg

相似文献

1
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.昆虫细胞表达的p180erbB3具有受损的酪氨酸激酶活性。
Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8132-6. doi: 10.1073/pnas.91.17.8132.
2
ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.ErbB3参与表皮生长因子对磷脂酰肌醇3激酶的激活过程。
Mol Cell Biol. 1994 Jun;14(6):3550-8. doi: 10.1128/mcb.14.6.3550-3558.1994.
3
Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera.利用表皮生长因子受体/c-erbB-3嵌合体鉴定磷脂酰肌醇3'-激酶和SHC的c-erbB-3结合位点。
EMBO J. 1994 Jun 15;13(12):2831-41. doi: 10.1002/j.1460-2075.1994.tb06577.x.
4
p120cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells.p120cbl是一种胞质衔接蛋白,在PC12细胞和其他细胞中,它会响应表皮生长因子与磷酸肌醇3激酶结合。
J Biol Chem. 1996 Jan 5;271(1):563-7. doi: 10.1074/jbc.271.1.563.
5
Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins.个别表皮生长因子受体自身磷酸化位点并不能严格界定几种含SH2结构域蛋白的结合基序。
J Biol Chem. 1994 Apr 22;269(16):12320-4.
6
Heparin stimulates epidermal growth factor receptor-mediated phosphorylation of tyrosine and threonine residues.肝素刺激表皮生长因子受体介导的酪氨酸和苏氨酸残基磷酸化。
Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5954-8. doi: 10.1073/pnas.88.14.5954.
7
Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells.活化的人表皮生长因子受体的酪氨酸1148和1173是完整细胞中Shc的结合位点。
J Biol Chem. 1994 Jul 15;269(28):18674-8.
8
Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.磷脂酰肌醇3激酶与erbB3基因产物的表皮生长因子依赖性关联。
J Biol Chem. 1994 Oct 7;269(40):24747-55.
9
Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members.与磷脂酰肌醇3激酶的有效偶联,而非磷脂酶Cγ或GTP酶激活蛋白,使ErbB - 3信号传导有别于其他ErbB/表皮生长因子受体(EGFR)家族成员的信号传导。
Mol Cell Biol. 1994 Jan;14(1):492-500. doi: 10.1128/mcb.14.1.492-500.1994.
10
Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85.大鼠嗜铬细胞瘤细胞中Heregulin刺激的信号传导。ErbB3与Neu/ErbB2和p85相互作用的证据。
J Biol Chem. 1995 Aug 11;270(32):19022-7. doi: 10.1074/jbc.270.32.19022.

引用本文的文献

1
Molecular Crosstalk and Therapeutic Synergy: Tyrosine Kinase Inhibitors and Cannabidiol in Oral Cancer Treatment.分子相互作用与治疗协同作用:酪氨酸激酶抑制剂与大麻二酚在口腔癌治疗中的应用
Curr Issues Mol Biol. 2025 Jul 23;47(8):584. doi: 10.3390/cimb47080584.
2
HER3: Unmasking a twist in the tale of a previously unsuccessful therapeutic pursuit targeting a key cancer survival pathway.HER3:揭示靶向关键癌症生存途径的先前未成功治疗探索中的一个转折。
Genes Dis. 2024 Jun 17;12(4):101354. doi: 10.1016/j.gendis.2024.101354. eCollection 2025 Jul.
3
Emerging importance of HER3 in tumorigenesis and cancer therapy.

本文引用的文献

1
Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.erbB - 3酪氨酸激酶的配体依赖性信号传导及其在人乳腺肿瘤细胞中的组成性激活的证明。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2900-4. doi: 10.1073/pnas.90.7.2900.
2
Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor.从表皮生长因子受体的同源性建模推导得出的确定酪氨酸激酶活性的结构特征。
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5001-5. doi: 10.1073/pnas.90.11.5001.
3
The erbB3 gene product is a receptor for heregulin.
HER3在肿瘤发生和癌症治疗中的重要性日益凸显。
Nat Rev Clin Oncol. 2025 May;22(5):348-370. doi: 10.1038/s41571-025-01008-y. Epub 2025 Mar 14.
4
Liver-derived Neuregulin1α stimulates compensatory pancreatic β cell hyperplasia in insulin resistance.肝脏来源的神经调节蛋白1α刺激胰岛素抵抗时胰腺β细胞的代偿性增生。
Nat Commun. 2025 Mar 13;16(1):1950. doi: 10.1038/s41467-025-57167-0.
5
EGFR- and Integrin αβ-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics.表皮生长因子受体(EGFR)和整合素 αβ 靶向肽作为潜在的放射性金属标记放射性药物用于癌症治疗。
Int J Mol Sci. 2024 Aug 5;25(15):8553. doi: 10.3390/ijms25158553.
6
Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications.基因融合——这些罕见基因改变背后还有哪些希望?生物学、诊断方法及临床意义的全面综述
Cancers (Basel). 2024 Aug 5;16(15):2766. doi: 10.3390/cancers16152766.
7
Trans-activating mutations of the pseudokinase ERBB3.表皮生长因子受体 3 的反式激活突变。
Oncogene. 2024 Jul;43(29):2253-2265. doi: 10.1038/s41388-024-03070-9. Epub 2024 May 28.
8
Quantitative systems pharmacology modeling of HER2-positive metastatic breast cancer for translational efficacy evaluation and combination assessment across therapeutic modalities.定量系统药理学模型用于评估 HER2 阳性转移性乳腺癌的治疗效果和不同治疗模式的联合治疗效果。
Acta Pharmacol Sin. 2024 Jun;45(6):1287-1304. doi: 10.1038/s41401-024-01232-9. Epub 2024 Feb 15.
9
Busting the Breast Cancer with AstraZeneca's Gefitinib.阿斯利康的吉非替尼抗击乳腺癌
Adv Pharmacol Pharm Sci. 2023 Dec 4;2023:8127695. doi: 10.1155/2023/8127695. eCollection 2023.
10
A PAX6-regulated receptor tyrosine kinase pairs with a pseudokinase to activate immune defense upon oomycete recognition in .在. 中,PAX6 调节的受体酪氨酸激酶与假激酶配对,以在卵菌识别时激活免疫防御。
Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2300587120. doi: 10.1073/pnas.2300587120. Epub 2023 Sep 19.
erbB3基因产物是神经调节蛋白的一种受体。
J Biol Chem. 1994 May 13;269(19):14303-6.
4
SH2 domains recognize specific phosphopeptide sequences.SH2结构域识别特定的磷酸肽序列。
Cell. 1993 Mar 12;72(5):767-78. doi: 10.1016/0092-8674(93)90404-e.
5
ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.ErbB3参与表皮生长因子对磷脂酰肌醇3激酶的激活过程。
Mol Cell Biol. 1994 Jun;14(6):3550-8. doi: 10.1128/mcb.14.6.3550-3558.1994.
6
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.erbB2和erbB3蛋白的共表达重建了对heregulin的高亲和力受体。
J Biol Chem. 1994 May 20;269(20):14661-5.
7
Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells.A431细胞来源的膜泡中与表皮生长因子受体相关的蛋白激酶的亲和标记
J Biol Chem. 1982 Apr 25;257(8):4019-22.
8
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
9
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.人类乳腺癌:HER-2/neu癌基因扩增与复发及生存的相关性。
Science. 1987 Jan 9;235(4785):177-82. doi: 10.1126/science.3798106.
10
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.蛋白激酶家族:催化结构域的保守特征与推导的系统发育
Science. 1988 Jul 1;241(4861):42-52. doi: 10.1126/science.3291115.